Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

<p>Abstract</p> <p>Background</p> <p>Dual antiplatelet therapy using acetylsalicylic acid (ASA, aspirin) and clopidogrel is of great importance following coronary stenting. However, the variable platelet inhibitory effectiveness compromises the antithrombotic advantages provided by dual antiplatelet...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Pepinghege Fenena, Lask Sebastian, Engelhardt Andreas, Krüger Jan C, Endres Heinz G, Kaiser Andreas FC, Neubauer Horst, Kusber Andreas, Mügge Andreas
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2011-01-01
Serier:	BMC Medicine
Online adgang:	http://www.biomedcentral.com/1741-7015/9/3
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!